SIRT7 and autoimmune thrombocytopenic purpura: These findings establish SIRT7 as a critical regulator of immune homeostasis and suggest that targeting SIRT7‐mediated desuccinylation may represent a novel therapeutic strategy for ITP with disrupted Th17/Treg dynamics.